CORONA Share Price | Corona Remedies Ltd Stock Analysis & Recommendation

Upcoming Result: Corona Remedies will declare its result soon on 11 May 2026

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

11.44 k (-64.40%) Volume

Shareholding (Mar 2026)

FII

2.25%

Held by 21 FIIs

DII

0.09%

Held by 9 DIIs

Promoter

69.00%

Why is Corona Remedies Ltd falling/rising?

06-May-2026

As of 05-May, the stock price of Corona Remedies Ltd is rising, currently at Rs. 1,752.55, reflecting an increase of Rs. 21.35 or 1.23%. The stock has shown strong performance with significant gains over various time frames, reaching a new all-time high, despite a decline in investor participation.

View full answer

Which are the latest news on Corona Remedies?

06-May-2026

No latest news for Corona Remedies found.

Compare Corona Remedies with Similar Stocks

Sanofi Consumer Strides Pharma Concord Biotech

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 10,802 Cr (Small Cap)

P/E

53.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.01

Return on Equity

24.61%

Price to Book

17.63

Revenue and Profits:

Net Sales:

342 Cr

(Quarterly Results - Dec 2025)

Net Profit:

41 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

13.67%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Corona Remedies for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Board Meeting Intimation for Consideration And Approval Of Audited Financial Results On Standalone And Consolidated Basis For The Fourth Quarter And Year Ended On March 31 2026

30-Apr-2026 | Source : BSE

Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 inter alia to consider and approve a) Audited Financial Results on Standalone and Consolidated basis for the Fourth Quarter and Year ended on March 31 2026; b) recommendation of final dividend if any on the equity shares of the Company for the financial year ended March 31 2026 for approval of the shareholders at the ensuing Annual General Meeting.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

30-Apr-2026 | Source : BSE

Intimation of Schedule of Analyst / Investor Call

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

07-Apr-2026 | Source : BSE

Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the fourth quarter ended March 31 2026

Corporate Actions

BOARD MEETING

11 May 2026

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

19.13

Debt to EBITDA (avg)

0.38

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.86

Tax Ratio

24.78%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

9.26%

ROCE (avg)

29.97%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

17.57

EV to EBIT

52.44

EV to EBITDA

44.32

EV to Capital Employed

17.75

EV to Sales

8.89

PEG Ratio

Dividend Yield

ROCE (Latest)

33.85%

ROE (Latest)

24.61%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Bullish

KST

Dow Theory

Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 17 Schemes (6.35%)

FIIs

Held by 21 FIIs (2.25%)

Promoter with highest holding

Ankurbhai K Mehta (22.0%)

Highest Public shareholder

Sepia Investments Limited (19.76%)

Individual Investors Holdings

0.77%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -5.18% vs 4.21% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -20.90% vs 12.39% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "342.42",
          "val2": "361.13",
          "chgp": "-5.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "83.16",
          "val2": "78.47",
          "chgp": "5.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.66",
          "val2": "1.93",
          "chgp": "-13.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-19.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "41.25",
          "val2": "52.15",
          "chgp": "-20.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.29%",
          "val2": "21.73%",
          "chgp": "2.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "707.67",
          "val2": "605.04",
          "chgp": "16.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "148.25",
          "val2": "116.34",
          "chgp": "27.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.92",
          "val2": "6.02",
          "chgp": "-34.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "98.55",
          "val2": "72.93",
          "chgp": "35.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.95%",
          "val2": "19.23%",
          "chgp": "1.72%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,050.09",
          "val2": "902.73",
          "chgp": "16.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "231.41",
          "val2": "185.76",
          "chgp": "24.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.58",
          "val2": "8.41",
          "chgp": "-33.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-19.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "139.80",
          "val2": "117.70",
          "chgp": "18.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.04%",
          "val2": "20.58%",
          "chgp": "1.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,196.42",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "239.98",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "10.60",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "149.05",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.06%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

342.42

361.13

-5.18%

Operating Profit (PBDIT) excl Other Income

83.16

78.47

5.98%

Interest

1.66

1.93

-13.99%

Exceptional Items

-19.10

0.00

Standalone Net Profit

41.25

52.15

-20.90%

Operating Profit Margin (Excl OI)

24.29%

21.73%

2.56%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -5.18% vs 4.21% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -20.90% vs 12.39% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

707.67

605.04

16.96%

Operating Profit (PBDIT) excl Other Income

148.25

116.34

27.43%

Interest

3.92

6.02

-34.88%

Exceptional Items

0.00

Standalone Net Profit

98.55

72.93

35.13%

Operating Profit Margin (Excl OI)

20.95%

19.23%

1.72%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,050.09

902.73

16.32%

Operating Profit (PBDIT) excl Other Income

231.41

185.76

24.57%

Interest

5.58

8.41

-33.65%

Exceptional Items

-19.10

0.00

Standalone Net Profit

139.80

117.70

18.78%

Operating Profit Margin (Excl OI)

22.04%

20.58%

1.46%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

1,196.42

Operating Profit (PBDIT) excl Other Income

239.98

Interest

10.60

Exceptional Items

0.00

Standalone Net Profit

149.05

Operating Profit Margin (Excl OI)

20.06%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Corona Remedies Ltd

Corona Remedies Ltd

Small Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available